APO Research
Talk to an analyst

APO RESEARCH · REPORT

Cell and Gene Therapy Services

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Cell and Gene Therapy Services Market Analysis and Forecast 2026-2032

4 June 2026216 pages

Choose your research edition.

Industry ResearchCell and Gene Therapy Services Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Cell and Gene Therapy Services Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Cell and Gene Therapy Services Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Cell and Gene Therapy Services Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Cell and Gene Therapy Services Market Analysis and Forecast 2026-2032216 pages · $4,950 USD

Market perspective

The global Cell and Gene Therapy Services market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Cell and Gene Therapy Services is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Cell and Gene Therapy Services is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Cell and Gene Therapy Services is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Cell and Gene Therapy Services is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Cell and Gene Therapy Services include BioIT Solutions, Lonza, SK pharmteco, Hypertrust, Qiagen, Bio-Techne, Promega, Tenthpin and Thermo Fisher, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Cell and Gene Therapy Services, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Cell and Gene Therapy Services, also provides the revenue of main regions and countries. Of the upcoming market potential for Cell and Gene Therapy Services, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Cell and Gene Therapy Services revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Cell and Gene Therapy Services market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Cell and Gene Therapy Services revenue, projected growth trends, production technology, application and end-user industry.

Cell and Gene Therapy Services Segment by Company

BioIT Solutions

Lonza

SK pharmteco

Hypertrust

Qiagen

Bio-Techne

Promega

Tenthpin

Thermo Fisher

Charles River

ACROBiosystems

Revvity

Pharmaron

Cell and Gene Therapy Services Segment by Type

Gene Therapy

Cell Therapy

Cell and Gene Therapy Services Segment by Application

Hospital

Clinic

Cell and Gene Therapy Services Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cell and Gene Therapy Services market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Cell and Gene Therapy Services and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cell and Gene Therapy Services.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Cell and Gene Therapy Services in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Cell and Gene Therapy Services company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Cell and Gene Therapy Services revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Cell and Gene Therapy Services Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Gene Therapy Major Player Table 3. Cell Therapy Major Player Table 4. Global Cell and Gene Therapy Services Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Hospital Major Player Table 6. Clinic Major Player Table 7. Cell and Gene Therapy Services Industry Trends Table 8. Cell and Gene Therapy Services Industry Drivers Table 9. Cell and Gene Therapy Services Industry Opportunities and Challenges Table 10. Cell and Gene Therapy Services Industry Restraints Table 11. Global Cell and Gene Therapy Services Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 12. Global Cell and Gene Therapy Services Market Size by Region (2021-2026) & (US$ Million) Table 13. Global Cell and Gene Therapy Services Market Share by Region (2021-2026) Table 14. Global Cell and Gene Therapy Services Market Size by Region (2027-2032) & (US$ Million) Table 15. Global Cell and Gene Therapy Services Market Share by Region (2027-2032) Table 16. Global Cell and Gene Therapy Services Revenue by Players (US$ Million) & (2021-2026) Table 17. Global Cell and Gene Therapy Services Revenue Market Share by Players (2021-2026) Table 18. Global Cell and Gene Therapy Services Key Players Ranking, 2024 VS 2025 VS 2026 Table 19. Global Cell and Gene Therapy Services Key Players Headquarters & Area Served Table 20. Global Cell and Gene Therapy Services Players, Product Type & Application Table 21. Global Cell and Gene Therapy Services Players Establishment Date Table 22. Global Players Market Concentration Ratio (CR5 and HHI) Table 23. Global Cell and Gene Therapy Services by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 24. Global Cell and Gene Therapy Services Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Cell and Gene Therapy Services Revenue by Type (2021-2026) & (US$ Million) Table 26. Global Cell and Gene Therapy Services Revenue by Type (2027-2032) & (US$ Million) Table 27. Global Cell and Gene Therapy Services Revenue Market Share by Type (2021-2026) Table 28. Global Cell and Gene Therapy Services Revenue Market Share by Type (2027-2032) Table 29. Global Cell and Gene Therapy Services Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Cell and Gene Therapy Services Revenue by Application (2021-2026) & (US$ Million) Table 31. Global Cell and Gene Therapy Services Revenue by Application (2027-2032) & (US$ Million) Table 32. Global Cell and Gene Therapy Services Revenue Market Share by Application (2021-2026) Table 33. Global Cell and Gene Therapy Services Revenue Market Share by Application (2027-2032) Table 34. BioIT Solutions Company Information Table 35. BioIT Solutions Business Overview Table 36. BioIT Solutions Cell and Gene Therapy Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 37. BioIT Solutions Cell and Gene Therapy Services Product Portfolio Table 38. BioIT Solutions Recent Development Table 39. Lonza Company Information Table 40. Lonza Business Overview Table 41. Lonza Cell and Gene Therapy Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 42. Lonza Cell and Gene Therapy Services Product Portfolio Table 43. Lonza Recent Development Table 44. SK pharmteco Company Information Table 45. SK pharmteco Business Overview Table 46. SK pharmteco Cell and Gene Therapy Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 47. SK pharmteco Cell and Gene Therapy Services Product Portfolio Table 48. SK pharmteco Recent Development Table 49. Hypertrust Company Information Table 50. Hypertrust Business Overview Table 51. Hypertrust Cell and Gene Therapy Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 52. Hypertrust Cell and Gene Therapy Services Product Portfolio Table 53. Hypertrust Recent Development Table 54. Qiagen Company Information Table 55. Qiagen Business Overview Table 56. Qiagen Cell and Gene Therapy Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 57. Qiagen Cell and Gene Therapy Services Product Portfolio Table 58. Qiagen Recent Development Table 59. Bio-Techne Company Information Table 60. Bio-Techne Business Overview Table 61. Bio-Techne Cell and Gene Therapy Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 62. Bio-Techne Cell and Gene Therapy Services Product Portfolio Table 63. Bio-Techne Recent Development Table 64. Promega Company Information Table 65. Promega Business Overview Table 66. Promega Cell and Gene Therapy Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 67. Promega Cell and Gene Therapy Services Product Portfolio Table 68. Promega Recent Development Table 69. Tenthpin Company Information Table 70. Tenthpin Business Overview Table 71. Tenthpin Cell and Gene Therapy Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 72. Tenthpin Cell and Gene Therapy Services Product Portfolio Table 73. Tenthpin Recent Development Table 74. Thermo Fisher Company Information Table 75. Thermo Fisher Business Overview Table 76. Thermo Fisher Cell and Gene Therapy Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 77. Thermo Fisher Cell and Gene Therapy Services Product Portfolio Table 78. Thermo Fisher Recent Development Table 79. Charles River Company Information Table 80. Charles River Business Overview Table 81. Charles River Cell and Gene Therapy Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 82. Charles River Cell and Gene Therapy Services Product Portfolio Table 83. Charles River Recent Development Table 84. ACROBiosystems Company Information Table 85. ACROBiosystems Business Overview Table 86. ACROBiosystems Cell and Gene Therapy Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 87. ACROBiosystems Cell and Gene Therapy Services Product Portfolio Table 88. ACROBiosystems Recent Development Table 89. Revvity Company Information Table 90. Revvity Business Overview Table 91. Revvity Cell and Gene Therapy Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 92. Revvity Cell and Gene Therapy Services Product Portfolio Table 93. Revvity Recent Development Table 94. Pharmaron Company Information Table 95. Pharmaron Business Overview Table 96. Pharmaron Cell and Gene Therapy Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 97. Pharmaron Cell and Gene Therapy Services Product Portfolio Table 98. Pharmaron Recent Development Table 99. North America Cell and Gene Therapy Services Revenue by Type (2021-2026) & (US$ Million) Table 100. North America Cell and Gene Therapy Services Revenue by Type (2027-2032) & (US$ Million) Table 101. North America Cell and Gene Therapy Services Revenue by Application (2021-2026) & (US$ Million) Table 102. North America Cell and Gene Therapy Services Revenue by Application (2027-2032) & (US$ Million) Table 103. North America Cell and Gene Therapy Services Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 104. North America Cell and Gene Therapy Services Revenue by Country (2021-2026) & (US$ Million) Table 105. North America Cell and Gene Therapy Services Revenue by Country (US$ Million) & (2027-2032) Table 106. Europe Cell and Gene Therapy Services Revenue by Type (2021-2026) & (US$ Million) Table 107. Europe Cell and Gene Therapy Services Revenue by Type (2027-2032) & (US$ Million) Table 108. Europe Cell and Gene Therapy Services Revenue by Application (2021-2026) & (US$ Million) Table 109. Europe Cell and Gene Therapy Services Revenue by Application (2027-2032) & (US$ Million) Table 110. Europe Cell and Gene Therapy Services Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 111. Europe Cell and Gene Therapy Services Revenue by Country (2021-2026) & (US$ Million) Table 112. Europe Cell and Gene Therapy Services Revenue by Country (US$ Million) & (2027-2032) Table 113. China Cell and Gene Therapy Services Revenue by Type (2021-2026) & (US$ Million) Table 114. China Cell and Gene Therapy Services Revenue by Type (2027-2032) & (US$ Million) Table 115. China Cell and Gene Therapy Services Revenue by Application (2021-2026) & (US$ Million) Table 116. China Cell and Gene Therapy Services Revenue by Application (2027-2032) & (US$ Million) Table 117. Asia Cell and Gene Therapy Services Revenue by Type (2021-2026) & (US$ Million) Table 118. Asia Cell and Gene Therapy Services Revenue by Type (2027-2032) & (US$ Million) Table 119. Asia Cell and Gene Therapy Services Revenue by Application (2021-2026) & (US$ Million) Table 120. Asia Cell and Gene Therapy Services Revenue by Application (2027-2032) & (US$ Million) Table 121. Asia Cell and Gene Therapy Services Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 122. Asia Cell and Gene Therapy Services Revenue by Region (US$ Million) & (2021-2026) Table 123. Asia Cell and Gene Therapy Services Revenue by Region (US$ Million) & (2027-2032) Table 124. SAMEA Cell and Gene Therapy Services Revenue by Type (2021-2026) & (US$ Million) Table 125. SAMEA Cell and Gene Therapy Services Revenue by Type (2027-2032) & (US$ Million) Table 126. SAMEA Cell and Gene Therapy Services Revenue by Application (2021-2026) & (US$ Million) Table 127. SAMEA Cell and Gene Therapy Services Revenue by Application (2027-2032) & (US$ Million) Table 128. SAMEA Cell and Gene Therapy Services Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 129. SAMEA Cell and Gene Therapy Services Revenue by Country (2021-2026) & (US$ Million) Table 130. SAMEA Cell and Gene Therapy Services Revenue by Country (US$ Million) & (2027-2032) Table 131. Research Programs/Design for This Report Table 132. Authors List of This Report Table 133. Secondary Sources Table 134. Primary Sources List of Figures Figure 1. Cell and Gene Therapy Services Image Figure 2. Global Cell and Gene Therapy Services Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Cell and Gene Therapy Services Market Size Share 2021 VS 2025 VS 2032 Figure 4. Gene Therapy Image Figure 5. Cell Therapy Image Figure 6. Global Cell and Gene Therapy Services Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Cell and Gene Therapy Services Market Size Share 2021 VS 2025 VS 2032 Figure 8. Hospital Image Figure 9. Clinic Image Figure 10. Global Cell and Gene Therapy Services Market Size (US$ Million) & (2021-2032) Figure 11. Global Cell and Gene Therapy Services Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Cell and Gene Therapy Services Market Share by Region: 2021 VS 2025 VS 2032 Figure 13. Global Cell and Gene Therapy Services Players Revenue Share Top 10 and Top 5 in 2025 Figure 14. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 15. Global Cell and Gene Therapy Services Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Cell and Gene Therapy Services Revenue Market Share 2021 VS 2025 VS 2032 Figure 17. Global Cell and Gene Therapy Services Revenue Market Share by Type (2021-2032) Figure 18. Global Cell and Gene Therapy Services Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Cell and Gene Therapy Services Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 20. Global Cell and Gene Therapy Services Revenue Market Share by Application (2021-2032) Figure 21. North America Cell and Gene Therapy Services Revenue YoY Growth (2021-2032) & (US$ Million) Figure 22. North America Cell and Gene Therapy Services Revenue Share by Type (2021-2032) Figure 23. North America Cell and Gene Therapy Services Revenue Share by Application (2021-2032) Figure 24. North America Cell and Gene Therapy Services Revenue Share by Country (2021-2032) Figure 25. United States Cell and Gene Therapy Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 26. Canada Cell and Gene Therapy Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 27. Mexico Cell and Gene Therapy Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Europe Cell and Gene Therapy Services Revenue YoY Growth (2021-2032) & (US$ Million) Figure 29. Europe Cell and Gene Therapy Services Revenue Share by Type (2021-2032) Figure 30. Europe Cell and Gene Therapy Services Revenue Share by Application (2021-2032) Figure 31. Europe Cell and Gene Therapy Services Revenue Share by Country (2021-2032) Figure 32. Germany Cell and Gene Therapy Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 33. France Cell and Gene Therapy Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 34. U.K. Cell and Gene Therapy Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. Italy Cell and Gene Therapy Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. Spain Cell and Gene Therapy Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Russia Cell and Gene Therapy Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Netherlands Cell and Gene Therapy Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Nordic Countries Cell and Gene Therapy Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. China Cell and Gene Therapy Services Revenue YoY Growth (2021-2032) & (US$ Million) Figure 41. China Cell and Gene Therapy Services Revenue Share by Type (2021-2032) Figure 42. China Cell and Gene Therapy Services Revenue Share by Application (2021-2032) Figure 43. Asia Cell and Gene Therapy Services Revenue YoY Growth (2021-2032) & (US$ Million) Figure 44. Asia Cell and Gene Therapy Services Revenue Share by Type (2021-2032) Figure 45. Asia Cell and Gene Therapy Services Revenue Share by Application (2021-2032) Figure 46. Asia Cell and Gene Therapy Services Revenue Share by Region (2021-2032) Figure 47. Japan Cell and Gene Therapy Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 48. South Korea Cell and Gene Therapy Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 49. India Cell and Gene Therapy Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. Australia Cell and Gene Therapy Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. Taiwan Cell and Gene Therapy Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Southeast Asia Cell and Gene Therapy Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. SAMEA Cell and Gene Therapy Services Revenue YoY Growth (2021-2032) & (US$ Million) Figure 54. SAMEA Cell and Gene Therapy Services Revenue Share by Type (2021-2032) Figure 55. SAMEA Cell and Gene Therapy Services Revenue Share by Application (2021-2032) Figure 56. SAMEA Cell and Gene Therapy Services Revenue Share by Country (2021-2032) Figure 57. Brazil Cell and Gene Therapy Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 58. Argentina Cell and Gene Therapy Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 59. Chile Cell and Gene Therapy Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Colombia Cell and Gene Therapy Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Peru Cell and Gene Therapy Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Saudi Arabia Cell and Gene Therapy Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Israel Cell and Gene Therapy Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. UAE Cell and Gene Therapy Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Turkey Cell and Gene Therapy Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Iran Cell and Gene Therapy Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Egypt Cell and Gene Therapy Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Years Considered Figure 69. Research Process Figure 70. Key Executives Interviewed

Scope & coverage.

Types
  • Gene Therapy
  • Cell Therapy
Applications
  • Hospital
  • Clinic
Companies covered
  • BioIT Solutions
  • Lonza
  • SK pharmteco
  • Hypertrust
  • Qiagen
  • Bio-Techne
  • Promega
  • Tenthpin
  • Thermo Fisher
  • Charles River
  • ACROBiosystems
  • Revvity
  • Pharmaron

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Cell and Gene Therapy Services Market by Type
  3. 1.2.1 Global Cell and Gene Therapy Services Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Gene Therapy
  5. 1.2.3 Cell Therapy
  6. 1.3 Cell and Gene Therapy Services Market by Application
  7. 1.3.1 Global Cell and Gene Therapy Services Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Hospital
  9. 1.3.3 Clinic
  10. 1.4 Assumptions and Limitations
  11. 1.5 Study Goals and Objectives
2 Cell and Gene Therapy Services Market Dynamics
  1. 2.1 Cell and Gene Therapy Services Industry Trends
  2. 2.2 Cell and Gene Therapy Services Industry Drivers
  3. 2.3 Cell and Gene Therapy Services Industry Opportunities and Challenges
  4. 2.4 Cell and Gene Therapy Services Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Cell and Gene Therapy Services Market Perspective (2021-2032)
  2. 3.2 Global Cell and Gene Therapy Services Growth Trends by Region
  3. 3.2.1 Global Cell and Gene Therapy Services Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Cell and Gene Therapy Services Market Size by Region (2021-2026)
  5. 3.2.3 Global Cell and Gene Therapy Services Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Cell and Gene Therapy Services Revenue by Players
  2. 4.1.1 Global Cell and Gene Therapy Services Revenue by Players (2021-2026)
  3. 4.1.2 Global Cell and Gene Therapy Services Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Cell and Gene Therapy Services Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Cell and Gene Therapy Services Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Cell and Gene Therapy Services Key Players Headquarters & Area Served
  7. 4.4 Global Cell and Gene Therapy Services Players, Product Type & Application
  8. 4.5 Global Cell and Gene Therapy Services Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Cell and Gene Therapy Services Market CR5 and HHI
  11. 4.6.3 2025 Cell and Gene Therapy Services Tier 1, Tier 2, and Tier 3
5 Cell and Gene Therapy Services Market Size by Type
  1. 5.1 Global Cell and Gene Therapy Services Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Cell and Gene Therapy Services Revenue by Type (2021-2032)
  3. 5.3 Global Cell and Gene Therapy Services Revenue Market Share by Type (2021-2032)
6 Cell and Gene Therapy Services Market Size by Application
  1. 6.1 Global Cell and Gene Therapy Services Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Cell and Gene Therapy Services Revenue by Application (2021-2032)
  3. 6.3 Global Cell and Gene Therapy Services Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 BioIT Solutions
  2. 7.1.1 BioIT Solutions Company Information
  3. 7.1.2 BioIT Solutions Business Overview
  4. 7.1.3 BioIT Solutions Cell and Gene Therapy Services Revenue and Gross Margin (2021-2026)
  5. 7.1.4 BioIT Solutions Cell and Gene Therapy Services Product Portfolio
  6. 7.1.5 BioIT Solutions Recent Developments
  7. 7.2 Lonza
  8. 7.2.1 Lonza Company Information
  9. 7.2.2 Lonza Business Overview
  10. 7.2.3 Lonza Cell and Gene Therapy Services Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Lonza Cell and Gene Therapy Services Product Portfolio
  12. 7.2.5 Lonza Recent Developments
  13. 7.3 SK pharmteco
  14. 7.3.1 SK pharmteco Company Information
  15. 7.3.2 SK pharmteco Business Overview
  16. 7.3.3 SK pharmteco Cell and Gene Therapy Services Revenue and Gross Margin (2021-2026)
  17. 7.3.4 SK pharmteco Cell and Gene Therapy Services Product Portfolio
  18. 7.3.5 SK pharmteco Recent Developments
  19. 7.4 Hypertrust
  20. 7.4.1 Hypertrust Company Information
  21. 7.4.2 Hypertrust Business Overview
  22. 7.4.3 Hypertrust Cell and Gene Therapy Services Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Hypertrust Cell and Gene Therapy Services Product Portfolio
  24. 7.4.5 Hypertrust Recent Developments
  25. 7.5 Qiagen
  26. 7.5.1 Qiagen Company Information
  27. 7.5.2 Qiagen Business Overview
  28. 7.5.3 Qiagen Cell and Gene Therapy Services Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Qiagen Cell and Gene Therapy Services Product Portfolio
  30. 7.5.5 Qiagen Recent Developments
  31. 7.6 Bio-Techne
  32. 7.6.1 Bio-Techne Company Information
  33. 7.6.2 Bio-Techne Business Overview
  34. 7.6.3 Bio-Techne Cell and Gene Therapy Services Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Bio-Techne Cell and Gene Therapy Services Product Portfolio
  36. 7.6.5 Bio-Techne Recent Developments
  37. 7.7 Promega
  38. 7.7.1 Promega Company Information
  39. 7.7.2 Promega Business Overview
  40. 7.7.3 Promega Cell and Gene Therapy Services Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Promega Cell and Gene Therapy Services Product Portfolio
  42. 7.7.5 Promega Recent Developments
  43. 7.8 Tenthpin
  44. 7.8.1 Tenthpin Company Information
  45. 7.8.2 Tenthpin Business Overview
  46. 7.8.3 Tenthpin Cell and Gene Therapy Services Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Tenthpin Cell and Gene Therapy Services Product Portfolio
  48. 7.8.5 Tenthpin Recent Developments
  49. 7.9 Thermo Fisher
  50. 7.9.1 Thermo Fisher Company Information
  51. 7.9.2 Thermo Fisher Business Overview
  52. 7.9.3 Thermo Fisher Cell and Gene Therapy Services Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Thermo Fisher Cell and Gene Therapy Services Product Portfolio
  54. 7.9.5 Thermo Fisher Recent Developments
  55. 7.10 Charles River
  56. 7.10.1 Charles River Company Information
  57. 7.10.2 Charles River Business Overview
  58. 7.10.3 Charles River Cell and Gene Therapy Services Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Charles River Cell and Gene Therapy Services Product Portfolio
  60. 7.10.5 Charles River Recent Developments
  61. 7.11 ACROBiosystems
  62. 7.11.1 ACROBiosystems Company Information
  63. 7.11.2 ACROBiosystems Business Overview
  64. 7.11.3 ACROBiosystems Cell and Gene Therapy Services Revenue and Gross Margin (2021-2026)
  65. 7.11.4 ACROBiosystems Cell and Gene Therapy Services Product Portfolio
  66. 7.11.5 ACROBiosystems Recent Developments
  67. 7.12 Revvity
  68. 7.12.1 Revvity Company Information
  69. 7.12.2 Revvity Business Overview
  70. 7.12.3 Revvity Cell and Gene Therapy Services Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Revvity Cell and Gene Therapy Services Product Portfolio
  72. 7.12.5 Revvity Recent Developments
  73. 7.13 Pharmaron
  74. 7.13.1 Pharmaron Company Information
  75. 7.13.2 Pharmaron Business Overview
  76. 7.13.3 Pharmaron Cell and Gene Therapy Services Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Pharmaron Cell and Gene Therapy Services Product Portfolio
  78. 7.13.5 Pharmaron Recent Developments
8 North America
  1. 8.1 North America Cell and Gene Therapy Services Revenue (2021-2032)
  2. 8.2 North America Cell and Gene Therapy Services Revenue by Type (2021-2032)
  3. 8.2.1 North America Cell and Gene Therapy Services Revenue by Type (2021-2026)
  4. 8.2.2 North America Cell and Gene Therapy Services Revenue by Type (2027-2032)
  5. 8.3 North America Cell and Gene Therapy Services Revenue Share by Type (2021-2032)
  6. 8.4 North America Cell and Gene Therapy Services Revenue by Application (2021-2032)
  7. 8.4.1 North America Cell and Gene Therapy Services Revenue by Application (2021-2026)
  8. 8.4.2 North America Cell and Gene Therapy Services Revenue by Application (2027-2032)
  9. 8.5 North America Cell and Gene Therapy Services Revenue Share by Application (2021-2032)
  10. 8.6 North America Cell and Gene Therapy Services Revenue by Country
  11. 8.6.1 North America Cell and Gene Therapy Services Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Cell and Gene Therapy Services Revenue by Country (2021-2026)
  13. 8.6.3 North America Cell and Gene Therapy Services Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Cell and Gene Therapy Services Revenue (2021-2032)
  2. 9.2 Europe Cell and Gene Therapy Services Revenue by Type (2021-2032)
  3. 9.2.1 Europe Cell and Gene Therapy Services Revenue by Type (2021-2026)
  4. 9.2.2 Europe Cell and Gene Therapy Services Revenue by Type (2027-2032)
  5. 9.3 Europe Cell and Gene Therapy Services Revenue Share by Type (2021-2032)
  6. 9.4 Europe Cell and Gene Therapy Services Revenue by Application (2021-2032)
  7. 9.4.1 Europe Cell and Gene Therapy Services Revenue by Application (2021-2026)
  8. 9.4.2 Europe Cell and Gene Therapy Services Revenue by Application (2027-2032)
  9. 9.5 Europe Cell and Gene Therapy Services Revenue Share by Application (2021-2032)
  10. 9.6 Europe Cell and Gene Therapy Services Revenue by Country
  11. 9.6.1 Europe Cell and Gene Therapy Services Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Cell and Gene Therapy Services Revenue by Country (2021-2026)
  13. 9.6.3 Europe Cell and Gene Therapy Services Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Cell and Gene Therapy Services Revenue (2021-2032)
  2. 10.2 China Cell and Gene Therapy Services Revenue by Type (2021-2032)
  3. 10.2.1 China Cell and Gene Therapy Services Revenue by Type (2021-2026)
  4. 10.2.2 China Cell and Gene Therapy Services Revenue by Type (2027-2032)
  5. 10.3 China Cell and Gene Therapy Services Revenue Share by Type (2021-2032)
  6. 10.4 China Cell and Gene Therapy Services Revenue by Application (2021-2032)
  7. 10.4.1 China Cell and Gene Therapy Services Revenue by Application (2021-2026)
  8. 10.4.2 China Cell and Gene Therapy Services Revenue by Application (2027-2032)
  9. 10.5 China Cell and Gene Therapy Services Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Cell and Gene Therapy Services Revenue (2021-2032)
  2. 11.2 Asia Cell and Gene Therapy Services Revenue by Type (2021-2032)
  3. 11.2.1 Asia Cell and Gene Therapy Services Revenue by Type (2021-2026)
  4. 11.2.2 Asia Cell and Gene Therapy Services Revenue by Type (2027-2032)
  5. 11.3 Asia Cell and Gene Therapy Services Revenue Share by Type (2021-2032)
  6. 11.4 Asia Cell and Gene Therapy Services Revenue by Application (2021-2032)
  7. 11.4.1 Asia Cell and Gene Therapy Services Revenue by Application (2021-2026)
  8. 11.4.2 Asia Cell and Gene Therapy Services Revenue by Application (2027-2032)
  9. 11.5 Asia Cell and Gene Therapy Services Revenue Share by Application (2021-2032)
  10. 11.6 Asia Cell and Gene Therapy Services Revenue by Country
  11. 11.6.1 Asia Cell and Gene Therapy Services Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Cell and Gene Therapy Services Revenue by Country (2021-2026)
  13. 11.6.3 Asia Cell and Gene Therapy Services Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Cell and Gene Therapy Services Revenue (2021-2032)
  2. 12.2 SAMEA Cell and Gene Therapy Services Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Cell and Gene Therapy Services Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Cell and Gene Therapy Services Revenue by Type (2027-2032)
  5. 12.3 SAMEA Cell and Gene Therapy Services Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Cell and Gene Therapy Services Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Cell and Gene Therapy Services Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Cell and Gene Therapy Services Revenue by Application (2027-2032)
  9. 12.5 SAMEA Cell and Gene Therapy Services Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Cell and Gene Therapy Services Revenue by Country
  11. 12.6.1 SAMEA Cell and Gene Therapy Services Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Cell and Gene Therapy Services Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Cell and Gene Therapy Services Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst